There is no increased risk to the health of the mother or the infant associated with this triple-ARV regimen, consisting of zidovudine, lamivudine and lopinavir/ritonavir.

• 由齐多夫定、拉米夫定和洛匹那韦/利托那韦三种药物的组合对母亲和婴儿的健康威胁没有增加。